Wednesday, July 8, 2026

pharma · Endometrial cancer · Specific Advanced Solid Tumors · ACRV

Acrivon Therapeutics

Acrivon Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Cambridge, USA HQ
2018 Founded
84 Employees
Public company Type
ACRV · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2018
Employees
84
Programs
4
Drugs
3
Patents
0
Intelligence · Clinical Trials

Acrivon Therapeutics clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Acrivon Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Acrivon Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Acrivon Therapeutics.

  1. ACR-368-201 — Phase 2

    Clinical update
  2. ACR-368 — Phase 2

    Clinical update
  3. Gemcitabine — Phase 2

    Clinical update
  4. ACR-2316 — Phase 1

    Clinical update

Trial registry

4 studies